Sponsor or institution
Clinical trials and research at Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
As of November 12, 2026, Find a Trial lists 124 clinical trials run by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University that are recruiting, in China. 2 were first registered in the last 30 days. By phase: Phase 2 (32), Phase 3 (20), Phase 1/2 (5), Phase 1 (4). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 124Clinical trials
- 2New in 30 days
- 1Country
Newest trials
All recruiting trials (124)
-
One-Finger Technique to identify the left upper ureter during para-aortic lymphadenectomy
This study tests a new surgical method to help surgeons find the left upper ureter during open para-aortic lymphadenectomy in women with gynecologic cancers.
-
MRG003 added to ongoing treatment after progression in EGFR-positive advanced thyroid cancer
In this study, researchers test whether adding MRG003 to a patient’s current thyroid cancer treatment can shrink tumors for those whose cancer initially responded but later progressed.
-
Reducing Endotoxin Burden in Septic Shock Patients on CRRT with the oXiris Filter
This trial tests whether using the oXiris hemofilter during continuous kidney replacement helps lower endotoxin levels in adults with septic shock who need CRRT.
-
First-line combo therapy with anlotinib, benmelstobart, and HAIC for unresectable HCC
This study tests whether adding benmelstobart and hepatic arterial infusion chemotherapy to anlotinib can help people with unresectable hepatocellular carcinoma respond to treatment as a first line.
-
Culmerciclib with endocrine therapy before surgery for early HER2-negative hormone receptor-positive breast cancer
This trial tests whether adding culmerciclib to an aromatase inhibitor before surgery helps women with certain early breast cancers better shrink tumors than an aromatase inhibitor alone.
-
Optical surface guidance for head and neck radiotherapy with open-face mask
This trial tests whether using optical surface guidance with an open-face mask during radiotherapy for head and neck cancer improves positioning and reduces movement compared with the standard closed mask approach.
-
AI assistant to help diagnose and treat urological diseases
A large language model-based AI tool called UroAgent will be developed and tested to help doctors diagnose and plan treatment for urinary stones, prostate cancer, and bladder cancer using past records and new patient data.
-
New combination therapy for HER2-positive muscle-invasive bladder cancer
A phase 2, multi-center study tests four sensitizing drugs with disitamab vedotin and toripalimab in adults with HER2-positive muscle-invasive bladder cancer to see if the treatment can lead to tumor reduction and potential bladder preservation.
-
TACE or HAIC with targeted therapy and immunotherapy for liver cancer
This study tests whether adding targeted drugs and immunotherapy to TACE or HAIC helps people with unresectable hepatocellular carcinoma.
-
TNK for Acute Ischemic Stroke in the Extended Time Window with Simple Imaging
This trial tests whether giving a single IV bolus of tenecteplase helps people with acute ischemic stroke 4.5 to 24 hours after onset, selected using a simple non-contrast CT scan.
-
Adebrelimab with neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma
This study tests whether giving adebrelimab with paclitaxel, carboplatin, and short-course radiotherapy before surgery helps ESCC patients.
-
Endoscopic skin-sparing versus conventional mastectomy for wound outcomes in breast cancer
This trial will test whether endoscopic skin-sparing mastectomy causes fewer wound complications and improves patient satisfaction compared with conventional mastectomy in women with unilateral invasive breast cancer and small-to-moderate breasts.
-
AI language tools to help tumor care teams write MDT reports
We will test whether AI language tools can help junior cancer doctors write MDT diagnosis and treatment reports more accurately and faster.
-
Combining ultrasound and cytology whole-slide images to predict cancer risk in indeterminate (Bethesda III) thyroid nodules
This project will test whether a deep learning model that merges ultrasound pictures and cytology whole-slide images can better predict which Bethesda III thyroid nodules are cancerous.
-
Engineered T cells targeting MAGE-A4 for advanced mesenchymal cancers
This trial will try using a patient's own T cells, reprogrammed to recognize MAGE-A4, to see if the treatment is safe and can shrink advanced mesenchymal tumors that show MAGE-A4.
-
Shock wave therapy for patellar tendinitis with or without a coordinated fascial center-point treatment
This trial will test whether adding a coordinated fascial center-point shock wave treatment to standard patellar tendon shock wave therapy reduces pain and improves knee function in adults aged 18–45 with patellar tendinitis.
-
Dezocine versus nalbuphine with sufentanil for pain control after oral cancer surgery with free-flap reconstruction
This will see if adding dezocine or nalbuphine to sufentanil reduces pain and complications for adults undergoing oral cancer surgery with free-flap reconstruction.
-
Extended-interval versus standard-interval immunotherapy for advanced triple-negative breast cancer
This trial tests whether giving immunotherapy less often works as well and causes fewer immune-related side effects than the standard schedule for adults with advanced triple-negative breast cancer who responded to initial combination therapy.
-
Ribociclib plus aromatase inhibitor after pre-surgery chemo for HR-positive, HER2-negative early breast cancer with leftover disease
This trial will test whether adding ribociclib to an aromatase inhibitor helps people with hormone receptor–positive, HER2–negative early breast cancer who still have invasive cancer after pre-surgery (neoadjuvant) chemotherapy.
-
rTMS plus hearing aids to help thinking in age-related hearing loss
This study will test whether daily high-frequency rTMS added to usual care can improve thinking skills and brain activity in older adults with age-related hearing loss, both those who do and do not use hearing aids, compared with older adults with normal hearing.
-
Acupuncture and compression to prevent chemotherapy-induced nerve damage in breast cancer
This trial will test whether wearing compression garments and/or receiving acupuncture during taxane chemotherapy can prevent chemotherapy-induced peripheral neuropathy in adults with early-stage breast cancer.
-
Sintilimab with chemotherapy before and after surgery for locally advanced oral squamous cell carcinoma
This trial will test whether adding sintilimab to chemotherapy before and after surgery helps people with locally advanced oral squamous cell carcinoma have fewer recurrences and better survival.
-
Comparing smaller, targeted surgery versus standard surgery after pre-surgery immunotherapy for locally advanced head and neck cancer
This trial tests whether smaller, response-guided surgery instead of the usual larger operation after neoadjuvant PD-1‑based chemoimmunotherapy works for people with resectable locally advanced head and neck squamous cell carcinoma who had a partial or complete response.
-
Trastuzumab-rezetecan for HER2-positive and HER2-low breast cancer
This project will test Trastuzumab-rezetecan in adults with HER2-positive or HER2-low breast cancer who are receiving it as part of routine care to see if it works and is safe.
-
Using contrast-enhanced ultrasound to predict lymph node spread in small papillary thyroid cancer
This will test whether contrast-enhanced ultrasound can predict lymph node spread before surgery in people with small (T1N0M0) papillary thyroid cancer.
-
Preoperative Right Hepatic Artery Embolization to enable surgery for advanced perihilar cholangiocarcinoma
A single-arm study tests whether embolizing the right hepatic artery before surgery helps patients with unresectable, locally advanced perihilar cholangiocarcinoma become eligible for radical liver surgery.
-
Camrelizumab plus apatinib with or without FOLFOX chemotherapy for advanced liver cancer
This research will test whether adding FOLFOX chemotherapy to camrelizumab plus apatinib helps adults with advanced hepatocellular carcinoma who have not received prior systemic treatment.
-
Personalized-target transcranial magnetic stimulation for chronic tinnitus
This trial will test whether TMS aimed at each person's auditory cortex using their resting-state MRI helps adults with chronic tinnitus more than standard TMS.
-
Herombopag for low platelets caused by T‑DM1 in breast cancer
This will test whether herombopag tablets can raise or stabilize platelet counts in breast cancer patients who developed low platelets after T‑DM1 so they can continue planned T‑DM1 cycles.
-
Omitting regional lymph node radiotherapy in low-risk node-positive breast cancer
This project will see if women with hormone-receptor positive, HER2-negative breast cancer who have 1–3 positive axillary nodes and a low RecurIndex can safely skip regional lymph node radiotherapy.
-
Adding intra-arterial clot-busting therapy to endovascular treatment for medium-vessel stroke
It tests whether adding intra-arterial clot-busting medicine to endovascular treatment helps adults with medium-vessel acute ischemic stroke who can be treated within 24 hours recover better.
-
Vitamin B3 to help immunotherapy work better in bladder cancer
A early-phase study tests whether Vitamin B3 can help immunotherapy drugs work better for adults with bladder cancer.
-
Neoadjuvant oral paclitaxel with subcutaneous pertuzumab and trastuzumab for HER2-positive breast cancer
This trial tests whether taking oral paclitaxel together with subcutaneous pertuzumab and trastuzumab before surgery helps people with HER2-positive breast cancer achieve a complete tumor response on pathology.
-
Tenecteplase IV thrombolysis for acute ischemic stroke after recent DOAC use
This will test whether a single IV dose of tenecteplase can improve 90-day recovery in adults who have an acute ischemic stroke and took a direct oral anticoagulant within the past 48 hours.
-
Skin-repair cream to prevent radiation dermatitis after breast cancer surgery
This phase 3 trial tests whether a natural weak-acid skin repair cream can prevent acute radiation dermatitis in adults who had mastectomy and are receiving adjuvant radiotherapy for breast cancer.
-
Microwave ablation for papillary thyroid microcarcinoma monitored with contrast-enhanced ultrasound and genetic testing
This project will try microwave ablation guided by contrast-enhanced ultrasound and an 88-gene panel in adults with low-risk papillary thyroid microcarcinoma to see if it controls the tumor while preserving thyroid function.
-
AI-guided ultrasound and MRI staging to guide bladder cancer treatment
This project will test whether a deep-learning system using ultrasound, MRI, and pathology can more accurately stage bladder cancer and predict who will benefit from additional chemotherapy for patients with suspected bladder tumors.
-
Trastuzumab rezetecan followed by CDK4/6 inhibitor plus hormone therapy for HR+/HER2‑low/ultra‑low advanced breast cancer
This trial will test whether starting with trastuzumab rezetecan and then switching to a CDK4/6 inhibitor plus endocrine therapy helps women with HR-positive, HER2-low or ultra-low advanced breast cancer live longer without disease progression.
-
Neoadjuvant immunochemotherapy for locally advanced cervical cancer
This trial will test whether giving paclitaxel and carboplatin together with a PD‑1/PD‑L1 immune checkpoint inhibitor before definitive treatment helps shrink tumors in patients with locally advanced cervical cancer (FIGO IB3–IIB) with tumors larger than 4 cm.
-
Using ctDNA to guide therapy for early triple negative breast cancer patients
This study is testing a new combination of treatments for early-stage triple negative breast cancer patients who still have cancer after initial therapy to see if it helps them do better.
-
External mastalgia oil versus placebo for severe breast pain in premenopausal women
This trial will test whether applying an external mastalgia oil reduces severe cyclical breast pain in premenopausal women compared with a placebo.
-
Combining arsenic trioxide, MAPK inhibitors, and chemotherapy for advanced neuroblastoma
This study is testing a new combination of arsenic trioxide, MAPK inhibitors, and chemotherapy to see if it can help people with advanced neuroblastoma feel better and improve their treatment outcomes.
-
Combining Apatinib, Adebrelimab, and Chemotherapy for Advanced Intrahepatic Cholangiocarcinoma
This study is testing a new treatment that combines two medications with chemotherapy to see if it can help people with advanced liver cancer respond better than with standard chemotherapy alone.
-
Probiotics to prevent neratinib-related diarrhea in HER2-positive breast cancer patients
This trial will test whether taking probiotics alongside standard preventive loperamide can reduce diarrhea in people with HER2-positive breast cancer who are starting neratinib compared with placebo.
-
Camrelizumab plus apatinib and eribulin versus physician's choice chemotherapy for advanced triple-negative breast cancer
This trial tests whether combining camrelizumab, apatinib, and eribulin works better than your doctor's chosen chemotherapy for adults with advanced triple-negative breast cancer who have had 1–4 prior systemic treatments.
-
Exploring HER2 Detection in Ovarian Cancer
This study is trying to find better ways to detect HER2 in ovarian cancer patients to help improve treatment options and outcomes.
-
Comparing domestic and imported hearing aids for age-related hearing loss
This study is testing whether hearing aids made in the U.S. work better than imported ones for older adults with age-related hearing loss.
-
Evaluating Trop2-ADC treatment for advanced triple-negative breast cancer
This study is testing a new treatment called Trop2-ADC, alone or with other therapies, to see if it helps people with advanced triple-negative breast cancer.
-
Using ultrasound to improve diagnosis of bladder cancer staging
This study is testing if using a special ultrasound technique can help doctors better determine the stage of bladder cancer in patients who haven't had treatment yet.
-
Crisugabalin for treating neuropathic pain after radiotherapy in head and neck cancer patients
This study is testing if Crisugabalin can help reduce nerve pain after radiation treatment in people with head and neck cancer better than Pregabalin.
-
MRI-based radiomics to predict pathology response after neoadjuvant therapy in head and neck cancer
This study tests whether MRI-derived radiomics features can predict which patients with head and neck squamous cell carcinoma will achieve a complete pathological response after neoadjuvant chemotherapy and PD-1–inhibitor therapy.
-
Assessing cervical lymph nodes response in head and neck cancer after treatment
This study is testing if a special ultrasound can help doctors see how well treatment is working on lymph nodes in patients with head and neck cancer.
-
AI system for identifying key structures in ear surgery
This study is testing a new AI system that helps surgeons find important parts of the ear during surgery to make the procedures safer and more effective.
-
Comparing microwave ablation and surgery for low-risk papillary thyroid cancer
This study is testing whether microwave ablation is a safe and effective alternative to surgery for people with low-risk papillary thyroid cancer.
-
Comparing endoscopic-assisted and conventional breast-conserving surgery for breast cancer patients
This study is testing whether a new type of breast surgery called endoscopic-assisted surgery works better than the traditional method for women with breast cancer who have already received treatment.
-
Hydroxychloroquine plus levothyroxine for improving live birth in euthyroid women with recurrent pregnancy loss and TPO antibodies
This trial will test whether adding hydroxychloroquine to levothyroxine increases the chance of a live birth for euthyroid women who have thyroid peroxidase antibodies and a history of recurrent pregnancy loss.
-
Evaluating Inetetamab combinations for treating HER2 positive metastatic breast cancer
This study is testing if a new drug called Inetetamab, used with either Pertuzumab or Pyrotinib, can improve treatment for people with HER2 positive metastatic breast cancer.
-
Transaxillary robotic thyroidectomy with modified radical neck dissection versus conventional open surgery for papillary thyroid cancer with lateral lymph node spread
This trial tests whether a transaxillary robotic thyroidectomy with modified radical neck dissection can provide similar cancer control but better cosmetic results and recovery than conventional open surgery for adults with papillary thyroid cancer that has spread to nearby neck lymph nodes.
-
Combination therapy for advanced liver cancer patients
This study is testing a new combination treatment for patients with advanced liver cancer to see if it can improve their chances of survival and how well they tolerate it.
-
Using donafenib after surgery for liver cancer
This study is testing if the drug donafenib can help prevent liver cancer from coming back in patients who have just had surgery to remove their tumors.
-
Effects of neoadjuvant therapy on pain, anxiety, and depression in head and neck cancer patients
This study is testing how a combination of chemotherapy and immunotherapy affects pain, anxiety, and depression in patients with head and neck cancer who are preparing for surgery.
-
Treatment of large jaw cysts using endoscopy and navigation technology
This study is testing a new way to remove large jaw cysts using advanced technology to see if it causes less nerve damage compared to traditional surgery for adults aged 18 to 75.
-
Observational study on CNS inflammatory demyelinating diseases in the Chinese population
This study is looking to understand how certain brain diseases, like Multiple Sclerosis, affect people in China and what factors might influence their progression and treatment.
-
Disitamab vedotin (RC48) with AK104 and bevacizumab for recurrent or persistent clear cell ovarian cancer
This trial tests whether combining a HER2-targeted antibody–drug conjugate (disitamab vedotin) with the PD-1/CTLA-4 bispecific AK104 and bevacizumab helps people with recurrent or persistent ovarian clear cell carcinoma.
-
AI-based diagnostic model for detecting lymphatic metastasis in cancer
This study is testing a new AI tool to see if it can better detect cancer spread to lymph nodes compared to the usual methods used by doctors.
-
Deep learning model for diagnosing skull-base osteonecrosis in nasopharyngeal carcinoma patients
This study is testing a new computer program to see if it can better diagnose a serious condition called skull-base osteonecrosis in people who have had treatment for nasopharyngeal cancer.
-
Identifying risk factors for sudden cardiac death
This study is trying to find warning signs for sudden cardiac death in people with heart conditions by looking at different health tests and markers to help catch risks early.
-
Ultrasound-guided carpal tunnel release procedure
This study is testing a new ultrasound-guided method for treating carpal tunnel syndrome to see if it can help patients recover faster and with less pain than traditional surgery.
-
Immediate angioplasty for severe stroke caused by narrowed arteries
This study is testing if immediate angioplasty, with or without a stent, can help people with severe strokes caused by narrowed arteries recover better than just using standard medical treatment.
-
Impact of socioeconomic factors on outcomes in young breast cancer patients after surgery
This study is trying to see how different socioeconomic factors affect the recovery and quality of life for young breast cancer patients in China after they have surgery.
-
Combining Camrelizumab with GEMOX for treating unresectable gallbladder cancer
This study is testing if combining a new drug called Camrelizumab with standard chemotherapy can help people with advanced gallbladder cancer live longer and feel better.
-
Combination treatment of Tislelizumab and Palbociclib for bladder cancer
This study is testing if combining two drugs, Tislelizumab and Palbociclib, can safely and effectively help people with bladder cancer that hasn't responded to other treatments.
-
Reducing radiation after surgery for advanced oral cancer
This study is testing if giving less radiation after surgery can still help people with advanced oral cancer who responded well to earlier treatments while reducing side effects.
-
Combination immunotherapy for advanced esophageal cancer
This study is testing a new combination of treatments for patients with advanced esophageal cancer who haven't responded to previous therapies to see if it can help them.
-
Combining Tislelizumab with chemotherapy before surgery for head and neck cancer
This study is testing if giving Tislelizumab with chemotherapy before surgery helps people with head and neck cancer do better than just having surgery right away.
-
Comparing two methods of breast reconstruction using the latissimus dorsi muscle
This study is testing two different ways to use a muscle from the back for breast reconstruction in women who don't want implants after cancer surgery to see which method leads to better satisfaction and results.
-
Combining capecitabine with camrelizumab for treating specific triple-negative breast cancer
This study is testing if combining a new drug called camrelizumab with capecitabine can help people with triple-negative breast cancer live longer and healthier after not responding fully to initial treatment.
-
Methotrexate plus tofacitinib for rheumatoid arthritis
This project will test whether adding tofacitinib to methotrexate helps adults with early, moderate-to-severe rheumatoid arthritis who have a myeloid-stromal synovial pattern.
-
AI system for diagnosing and predicting outcomes of breast phyllodes tumors
This study is testing whether an AI system can help doctors better diagnose and predict outcomes for patients with rare breast phyllodes tumors.
-
Chemotherapy with Adebrelimab and Apatinib for Biliary Tract Cancer Treatment
This study is testing a new combination of chemotherapy and two drugs, Adebrelimab and Apatinib, to see if it can help patients with a specific type of bile duct cancer who are at high risk of their cancer coming back after surgery.
-
Comparing disitamab vedotin and pyrotinib to standard treatment for HER2-positive advanced breast cancer
This study is testing a new combination of disitamab vedotin and pyrotinib to see if it works better than the standard treatment for people with newly diagnosed HER2-positive advanced breast cancer.
-
Fluzoparib plus apatinib versus physician-selected chemotherapy for HRD-positive, HER2-negative advanced breast cancer
This trial will test whether combining the PARP inhibitor fluzoparib with the anti-angiogenic drug apatinib works better than doctors' choice chemotherapy for adults with HRD-positive, HER2-negative advanced breast cancer.
-
Comparing two treatment methods for advanced liver cancer
This study is testing two different treatment methods for advanced liver cancer to see which one helps patients feel better and live longer.
-
Transcatheter repair for severe mitral regurgitation in low to intermediate surgery risk patients
This study is testing if a new heart valve repair method can safely help people with severe mitral regurgitation who are at low to intermediate risk for surgery.
-
Reconstruction of throat defects after cancer surgery using a specific flap technique
This study is testing a new way to rebuild the throat after cancer surgery to see if it works well and helps people recover better than other methods.
-
Contrast-enhanced ultrasound to improve scoring for thyroid cancer diagnosis
This project will test whether adding contrast-enhanced ultrasound to gray-scale ultrasound helps doctors better tell which thyroid nodules are cancerous for patients who have had biopsies.
-
Combining Tirellizumab with chemotherapy for early oral cancer treatment
This study is testing if combining a new drug called Tirellizumab with chemotherapy can help people with early-stage oral cancer avoid surgery and improve their treatment outcomes.
-
Using immune cells from lymph nodes to treat HER2-negative breast cancer
This study is testing if using immune cells from lymph nodes can help women with HER2-negative breast cancer who didn't respond to initial chemotherapy feel better before surgery.
-
Using immune cells from lymph nodes to treat advanced HER2-negative breast cancer
This study is testing whether using immune cells taken from lymph nodes can help people with advanced HER2-negative breast cancer feel better when combined with chemotherapy.
-
Using arsenic trioxide with chemotherapy to treat pediatric cancer with p53 mutations
This study is testing if adding arsenic trioxide to chemotherapy can help children with Li-Fraumeni syndrome and p53 mutations fight their cancer more safely.
-
Comparing cold dissection and electrocautery in nipple-sparing mastectomy with reconstruction
This study is testing whether using cold dissection instead of electrocautery during nipple-sparing mastectomy can lead to fewer complications and better cosmetic results for patients getting breast reconstruction.
-
Using immune cells from lymph nodes to treat HER2-negative breast cancer
This study is testing if using immune cells from lymph nodes can help women with HER2-negative breast cancer who didn't respond to their first round of chemotherapy feel better before surgery.
-
Using immune cells from lymph nodes to treat advanced HER2-negative breast cancer
This study is testing a new treatment using immune cells from lymph nodes to see if it can help people with advanced HER2-negative breast cancer when other options are limited.
-
Comparing PD-1 inhibitor therapy to radiotherapy for advanced head and neck cancer after immunochemotherapy
This study is testing if a new type of cancer treatment called PD-1 inhibitor therapy can be a better option than regular radiotherapy for patients with advanced head and neck cancer who have responded well to earlier treatment.
-
Comparing two and four courses of pembrolizumab with chemotherapy for head and neck cancer
This study is testing whether getting two or four rounds of a new cancer drug along with chemotherapy helps people with head and neck cancer do better before surgery.
-
Combining autophagy inhibition with CDK4/6 inhibitors for advanced solid tumors
This study is testing a new combination of two medications, Palbociclib and hydroxychloroquine, to see if it can help people with advanced solid tumors who haven't had success with previous treatments.
-
Using Mycophenolate Mofetil for Gastrointestinal Issues in Children with Henoch-Schönlein Purpura
This study tests if a medication called Mycophenolate Mofetil can help children aged 3 to 18 with stubborn stomach problems caused by Henoch-Schönlein Purpura when other treatments haven't worked.
-
Tirelizumab combined with chemotherapy for treating head and neck cancer
This study is testing if a new combination of tirelizumab and chemotherapy can help people with head and neck cancer feel better and improve their treatment results before and after surgery.
-
Using leflunomide to treat skin Henoch-Schonlein Purpura in children
This study is testing if adding leflunomide to steroid treatment can help children with stubborn skin Henoch-Schonlein Purpura have fewer rashes and feel better.
-
Using Leflunomide to treat children with Idiopathic Pulmonary Hemosiderosis
This study is testing if adding Leflunomide to steroid treatment can help children with Idiopathic Pulmonary Hemosiderosis feel better and protect their lung function.
-
Disitamab Vedotin for treating hormone receptor positive, HER2-low metastatic breast cancer
This study is testing a new drug called Disitamab Vedotin to see if it can help people with hormone receptor positive, HER2-low metastatic breast cancer who haven't responded to standard treatments.
-
Robotic surgery for early gastric cancer using a new technique
This study is testing a new robotic surgery technique for early stomach cancer to see if it can help patients recover better and have fewer problems after surgery compared to the usual method.
-
Using AI to help detect parathyroid glands during thyroid surgery
This study is testing a new AI tool to help surgeons find and protect the parathyroid glands during thyroid surgery to improve recovery and reduce the risk of complications.
-
Prolonged vaginal progesterone to help prevent preterm birth after IVF with fresh embryos
In people undergoing IVF with a fresh embryo, this study tests whether extending vaginal progesterone treatment reduces the risk of preterm birth.
-
Treatment for hormone receptor positive HER2 positive breast cancer after neoadjuvant therapy
This study is testing if combining two drugs, trastuzumab and nelatinib, can help people with hormone receptor positive HER2 positive breast cancer who still have cancer after initial treatment feel better compared to the usual combination of trastuzumab and pertuzumab.
-
Investigating cognitive function changes in older adults with hearing loss using hearing aids
This study is testing if using hearing aids can help older adults with hearing loss think better and lower their chances of developing dementia.
-
New treatment approach for relapsed childhood leukemia using arsenic compounds
This study is testing a new treatment using arsenic compounds combined with standard chemotherapy to see if it can help children with relapsed acute lymphoblastic leukemia feel better and have a better chance of recovery.
-
Combining Tislelizumab with chemotherapy before surgery for head and neck cancer
This study is testing if giving Tislelizumab along with chemotherapy before surgery can help people with head and neck cancer do better than having surgery right away.
-
Immunotherapy for Liver Cancer Patients Before Transplantation
This study is testing if a new immunotherapy treatment can help liver cancer patients shrink their tumors enough to qualify for a liver transplant.
-
Using PD-1 antibody and GEMOX for treating perihilar cholangiocarcinoma after surgery
This study is testing if a combination of a PD-1 antibody and GEMOX chemotherapy can help patients with perihilar cholangiocarcinoma who have had surgery and have cancer in their lymph nodes live longer and feel better.
-
Analyzing data on metastatic ovarian cancer using multi-omics
This study looks at tissue samples from patients with metastatic ovarian cancer to see if understanding the cancer's genetic and molecular features can help find new treatment options.
-
Detecting muscle invasion in bladder cancer using ultrasound
This study is testing if a special type of ultrasound can help doctors tell the difference between non-muscle invasive and muscle invasive bladder cancer before surgery to improve treatment options for patients.
-
Comparing two treatment regimens for HER-2 positive breast cancer
This study is testing two different treatment plans for people with HER-2 positive breast cancer to see which one works better before surgery.
-
Combining sintilimab with reduced chemotherapy for oral cavity cancer treatment
This study is testing if combining a new immune therapy called sintilimab with fewer chemotherapy sessions can help people with certain types of mouth cancer before they have surgery.
-
Preoperative treatment for salivary gland cancer using Sintilimab, Carboplatin, and Nab-paclitaxel
This study is testing a new treatment using Sintilimab, carboplatin, and nab-paclitaxel before surgery to see if it can help people with salivary gland cancer by boosting their immune response and shrinking the tumors.
-
Using Toripalimab after surgery and radiation for head and neck cancer
This study is testing if Toripalimab can help people with advanced head and neck cancer feel better after they have surgery and radiation.
-
Preoperative treatment for head and neck cancer using Toripalimab with chemotherapy
This study is testing if the drug Toripalimab, alone or with chemotherapy, can safely help people with head and neck cancer before their surgery.
-
Using ctDNA to guide therapy after surgery in triple negative breast cancer
This study is testing if checking for tumor DNA in the blood after surgery can help doctors give extra treatment to high-risk patients with triple negative breast cancer to improve their chances of recovery.
-
Combination of Fulvestrant and Pyrotinib for Advanced Breast Cancer
This study is testing if a new combination of fulvestrant and pyrotinib can help people with advanced breast cancer feel better and have fewer side effects than the standard treatment.
-
Using ctDNA to guide therapy after surgery in triple-negative breast cancer
This study is testing if using a blood test to find leftover cancer DNA after surgery can help doctors choose better treatments for people with triple-negative breast cancer who are at risk of relapse.
-
Observing cognitive impairment in older adults
This study looks at older adults to see how mild cognitive impairment and dementia develop, hoping to find better ways to prevent and treat these conditions.
-
Comparing fulvestrant and capecitabine for maintenance therapy in metastatic breast cancer
This study is testing whether fulvestrant or capecitabine works better as a follow-up treatment for women with hormone receptor-positive, HER2-negative metastatic breast cancer after their first chemotherapy.
-
Guiding radiation treatment for certain breast cancer patients
This study tests if skipping regional radiation for certain breast cancer patients who are at low risk can lead to better health outcomes after surgery.
-
Evaluating nervous system complications from radiotherapy
This study is trying to see how radiotherapy affects the nervous system in patients and what can be done to help them feel better.
Quick answers
How many clinical trials run by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University are recruiting right now?
124, as of November 12, 2026. 2 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 32, Phase 3: 20, Phase 1/2: 5, Phase 1: 4. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.